| Income Statement |
| Total Revenue | 20.00K |
|
| Revenues (USD) | 20.00K |
| Cost of Revenue | 4.00K |
| Gross Profit | 16.00K |
| Operating Expenses | 2.54M |
| Research and Development Expense | 913.00K |
| Selling, General and Administrative Expense | 1.66M |
| Operating Income | -2.53M |
| Interest Expense | 283.00K |
| Net Income | -19.37M |
| Net Income Common Stock | -19.37M |
| Net Income Common Stock (USD) | -19.37M |
| Consolidated Income | -19.37M |
| Earnings per Basic Share | -1.34 |
| Earnings per Basic Share (USD) | -1.34 |
| Earnings per Diluted Share | -1.34 |
| Earning Before Interest & Taxes (EBIT) | -19.09M |
| Earning Before Interest & Taxes (USD) | -19.09M |
| Weighted Average Shares | 14.44M |
| Weighted Average Shares Diluted | 14.44M |
| Balance Sheet |
| Cash and Equivalents | 7.57M |
| Cash and Equivalents (USD) | 7.57M |
| Trade and Non-Trade Receivables | 3.00K |
| Current Assets | 8.80M |
| Property, Plant & Equipment Net | 676.00K |
| Total Assets | 9.48M |
| Debt Current | 378.00K |
| Total Debt | 608.00K |
| Current Liabilities | 3.84M |
| Debt Non-Current | 230.00K |
| Total Liabilities | 4.07M |
| Accumulated Retained Earnings (Deficit) | -144.50M |
| Accumulated Other Comprehensive Income | -2.67M |
| Shareholders Equity | 5.41M |
| Shareholders Equity (USD) | 5.41M |
| Assets Non-Current | 676.00K |
| Total Debt (USD) | 608.00K |
| Deferred Revenue | 106.00K |
| Liabilities Non-Current | 230.00K |
| Trade and Non-Trade Payables | 3.36M |
| Tax Assets | 536.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 108.00K |
| Net Cash Flow from Financing | 8.60M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.19M |
| Issuance (Purchase) of Equity Shares | 3.02M |
| Issuance (Repayment) of Debt Securities | 1.15M |
| Net Cash Flow from Operations | -1.57M |
| Effect of Exchange Rate Changes on Cash | 161.00K |
| Share Based Compensation | 255.00K |